Skip to content
← Full study record

NCT02511522 · OUTCOME

Proportion of Patients Achieving a 25% Reduction in Opioid Use at 30 Days (Employing Daily Morphine Equivalence Scale).

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases · Source last updated 2024-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
30 days

Analysis population: Patients who reported taking opioid medications in the 24 hours prior to their both baseline and day 30 assessments

Groups in this outcome

Radiotherapy Combined With Best Supportive Care

Patients receive a radiation therapy with the use of 8 Gy in one fraction to the whole (or near-whole) liver together with the best supportive care.

Best Supportive Care Alone

Patients receive only the best supportive care.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Radiotherapy Combined With Best Supportive Care14
Best Supportive Care Alone14

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Radiotherapy Combined With Best Supportive Care5Not reportedNot reportedNot reportedNot reported
Best Supportive Care Alone3Not reportedNot reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.45
    statistical Comment
    adjusting for the stratification factor (Hepatocellular carcinoma versus liver metastases)
    statistical Method
    Cochran-Mantel-Haenszel
Complete source fields
analyses
  1. group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.45
    statistical Comment
    adjusting for the stratification factor (Hepatocellular carcinoma versus liver metastases)
    statistical Method
    Cochran-Mantel-Haenszel
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        5
      2. group Id
        OG001
        value
        3
denoms
  1. counts
    1. group Id
      OG000
      value
      14
    2. group Id
      OG001
      value
      14
    units
    Participants
groups
  1. description
    Patients receive a radiation therapy with the use of 8 Gy in one fraction to the whole (or near-whole) liver together with the best supportive care.
    id
    OG000
    title
    Radiotherapy Combined With Best Supportive Care
  2. description
    Patients receive only the best supportive care.
    id
    OG001
    title
    Best Supportive Care Alone
param Type
COUNT_OF_PARTICIPANTS
population Description
Patients who reported taking opioid medications in the 24 hours prior to their both baseline and day 30 assessments
reporting Status
POSTED
time Frame
30 days
title
Proportion of Patients Achieving a 25% Reduction in Opioid Use at 30 Days (Employing Daily Morphine Equivalence Scale).
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice